Andrew CHRISTIE SCHWARZ 医师
博士研究员
Vital vulval vivacity - Intimate rejuvenation for cis and transgendered patients
Objectives: With a global market estimated at 3.57 billion USD, female intimate rejuvenation is expected to grow at a compound annual rate of 22.07% until 2030. More than a mere makeover, vulval wellbeing is linked directly to patient social, cultural, sexual and relationship and personal confidence. What innovative, comfortable, effective and scientific solutions can now be offered to the modern cis and transgendered patient?
Introduction: The vulva describes the external female genital organs, including the labia majora, labia minora, clitoris, vaginal opening, urethra and mons pubis. Aesthetic intimate rejuvenation of the vulva focuses particularly on the reduction of hyperpigmentation and the visual plumping and hydration of labial and surrounding tissue. Treatments may also target in-grown hairs and compromised skin texture & tone. Post-operative transgender patients are particularly affected by the aesthetic appearance of the vulva and surrounding areas.
Materials / method: Whilst topical depigmenting, “pinking” gels, creams and lotions have served as an easy at-home (albeit temporary and limited solution), chemical peels or energy-based in-clinic procedures have been the benchmark for professional, vulval rejuvenation. Despite some success, longevity of results, patient comfort and treatment affordability can often result in disappointment, particularly for skins of colour, deemed unsuitable for chemical abrasion or thermolysis. Traditional resurfacing agents can also aggravate patients affected by heat, friction and other inflammatory triggers.
Results: Whilst not a replacement for surgical intervention or treatments targeting incontinence or prolapse, the unique innovation of automated skin-needling, combined with precision meso-infusion, intervenes melanin synthetic pathways, providing incredible success for the treatment of post-inflammatory hyperpigmentation, reduction of in-grown hairs and increased skin hydration, addressing aesthetic texture, tone and tissue quality. The post-operative application of an anabolic chemical peel accelerates the turnover of oxidised, darkened cells. Treatment is fast, comfortable and suitable for all skins
Conclusion: Procedural focus is applied to the external genital area and serves synergistically with other modalities to treat all aspects of vaginal health and rejuvenation. Procedures may be undertaken as frequently as every 2-4 weeks and can be performed in as little as a few minutes, without ablation, thermolysis or use of a topical local anaesthetic. Results may be apparent after just two procedures with some studies reporting 100% success rate with positive patient response.
Patient commitment to a topical, gentle pigment inhibitor, further enables management of PIH and tissue integrity